Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$597M |
| 2 |
Meta Platforms (Facebook)
META
|
+$497M |
| 3 |
Otis Worldwide
OTIS
|
+$377M |
| 4 |
T-Mobile US
TMUS
|
+$333M |
| 5 |
AbbVie
ABBV
|
+$312M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Apple
AAPL
|
+$457M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$427M |
| 5 |
Accenture
ACN
|
+$245M |
Sector Composition
| 1 | Technology | 23.73% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Cocrystal Pharma
COCP
$14.9M
| $400K | ﹤0.01% |
21,979
+18,489
| +530% | +$336K |
|
3427
Marchex
MCHX
$88.4M
| $400K | ﹤0.01% |
253,640
-230,885
| -48% | -$364K |
|
3428
Twin Disc
TWIN
$192M
| $399K | ﹤0.01% |
72,114
-61,126
| -46% | -$338K |
|
|
SELF
3429
Global Self Storage
SELF
$58.3M
| $398K | ﹤0.01% |
101,782
| – | – |
|
|
NMRD
3430
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
| $397K | ﹤0.01% |
+42,945
| New | +$397K |
|
3431
Amtech Systems
ASYS
$114M
| $396K | ﹤0.01% |
81,461
| – | – |
|
|
CLLS
3432
Cellectis
CLLS
$286M
| $396K | ﹤0.01% |
22,299
-3,394
| -13% | -$60.3K |
|
3433
Clarivate
CLVT
$2.96B
| $394K | ﹤0.01% |
+17,674
| New | +$394K |
|
3434
Synlogic
SYBX
$17.1M
| $394K | ﹤0.01% |
12,971
-5,791
| -31% | -$176K |
|
3435
EyePoint Pharmaceuticals
EYPT
$978M
| $393K | ﹤0.01% |
51,980
-37,378
| -42% | -$283K |
|
|
SOHU
3436
Sohu.com
SOHU
$481M
| $393K | ﹤0.01% |
42,723
+10,602
| +33% | +$97.5K |
|
3437
Corvus Pharmaceuticals
CRVS
$460M
| $392K | ﹤0.01% |
144,362
+5,446
| +4% | +$14.8K |
|
3438
DiaMedica Therapeutics
DMAC
$373M
| $390K | ﹤0.01% |
56,412
-1,112
| -2% | -$7.69K |
|
3439
SEACOR Marine Holdings
SMHI
$167M
| $388K | ﹤0.01% |
152,493
-117,080
| -43% | -$298K |
|
3440
STRATTEC Security
STRT
$280M
| $388K | ﹤0.01% |
24,344
| – | – |
|
|
CBL
3441
DELISTED
CBL& Associates Properties, Inc.
CBL
| $388K | ﹤0.01% |
1,426,832
-1,812,752
| -56% | -$493K |
|
|
GNCA
3442
DELISTED
Genocea Biosciences, Inc.
GNCA
| $388K | ﹤0.01% |
169,001
+18,036
| +12% | +$41.4K |
|
|
HZN
3443
DELISTED
Horizon Global Corporation
HZN
| $385K | ﹤0.01% |
175,350
| – | – |
|
|
AIM
3444
AIM ImmunoTech Inc.
AIM
$6.96M
| $383K | ﹤0.01% |
+1,548
| New | +$383K |
|
|
LUMO
3445
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $382K | ﹤0.01% |
23,192
+681
| +3% | +$11.2K |
|
|
SY
3446
So-Young International
SY
$411M
| $381K | ﹤0.01% |
28,082
+14,201
| +102% | +$193K |
|
3447
vTv Therapeutics
VTVT
$49.1M
| $379K | ﹤0.01% |
4,219
+1,583
| +60% | +$142K |
|
|
ALPN
3448
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $376K | ﹤0.01% |
38,774
+1,338
| +4% | +$13K |
|
3449
Lyra Therapeutics
LYRA
$10.8M
| $375K | ﹤0.01% |
+663
| New | +$375K |
|
3450
WPP
WPP
$5.89B
| $371K | ﹤0.01% |
+9,506
| New | +$371K |
|